معرفی
Qiang Chen is a Professor at Arizona State University's School of Life Sciences and the Biodesign Center for Bioelectronics and Biosensors. His research focuses on developing plant-based therapeutics and vaccines to combat infectious diseases, cancer, and biological threats. He specializes in monoclonal antibody engineering and has pioneered strategies to enhance antibody efficacy while minimizing risks like antibody-dependent enhancement (ADE). Professor Chen's work integrates biotechnology, immunology, and plant science, with a strong emphasis on translational research for clinical applications.
His research interests include Flavivirus therapeutics (e.g., Dengue, West Nile, Zika), SARS-CoV-2 treatments, and cancer-targeting antibodies. He has developed plant-made antibodies with improved CNS penetration and safety profiles. Key achievements include the 2025 Senior Membership in the National Academy of Inventors and over 20 patents on plant-derived biologics, including monoclonal antibodies and vaccine platforms.
Professor Chen has extensive industry experience under FDA cGMP guidelines, bridging academic research with biopharmaceutical manufacturing. He mentors students in areas like antibody engineering and clinical trial design. His labs and collaborations focus on advancing plant-based production systems for scalable, cost-effective biologics.
